Shenoy Erica S, Lee Hang, Cotter Jessica A, Ware Winston, Kelbaugh Douglas, Weil Eric, Walensky Rochelle P, Hooper David C
Harvard Medical School, Boston, MA; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA; Infection Control Unit, Massachusetts General Hospital, Boston, MA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA.
Department of Biostatistics, Massachusetts General Hospital, Boston, MA.
Am J Infect Control. 2016 Feb;44(2):215-21. doi: 10.1016/j.ajic.2015.08.019. Epub 2015 Oct 2.
A history of methicillin-resistant Staphylococcus aureus (MRSA) is a determinant of inpatient bed assignment.
We assessed outcomes associated with rapid testing and discontinuation of MRSA contact precautions (CP) in a prospective cohort study of polymerase chain reaction (PCR)-based screening in the Emergency Department (ED) of Massachusetts General Hospital. Eligible patients had a history of MRSA and were assessed and enrolled if documented off antibiotics with activity against MRSA and screened for nasal colonization (subject visit). PCR-negative subjects had CP discontinued; the primary outcome was CP discontinuation. We identified semiprivate rooms in which a bed was vacant owing to the CP status of the study subject, calculated the hours of vacancy, and compared idle bed-hours by PCR results. Program costs were compared with predicted revenue.
There were 2864 eligible patients, and 648 (22.6%) subject visits were enrolled. Of these, 65.1% (422/648) were PCR-negative and had CP discontinued. PCR-negative subjects had fewer idle bed-hours compared with PCR-positive subjects (28.6 ± 25.2 vs 75.3 ± 70.5; P < .001). The expected revenues from occupied idle beds and averted CP costs ranged from $214,160 to $268,340, and exceeded the program costs.
A program of targeted PCR-based screening for clearance of MRSA colonization resulted in expected revenues and decreased CP costs that outweighed programmatic costs.
耐甲氧西林金黄色葡萄球菌(MRSA)感染史是住院床位分配的一个决定因素。
在马萨诸塞州总医院急诊科进行的一项基于聚合酶链反应(PCR)筛查的前瞻性队列研究中,我们评估了与快速检测及停用MRSA接触预防措施(CP)相关的结果。符合条件的患者有MRSA感染史,若有停用对MRSA有活性的抗生素的记录并接受鼻腔定植筛查(受试者就诊),则进行评估并纳入研究。PCR检测阴性的受试者停用CP;主要结局是停用CP。我们确定了因研究对象的CP状态而有空床的半私人病房,计算空床小时数,并根据PCR结果比较闲置床小时数。将项目成本与预测收入进行比较。
有2864名符合条件的患者,648次(22.6%)受试者就诊被纳入研究。其中,65.1%(422/648)PCR检测阴性并停用了CP。与PCR检测阳性的受试者相比,PCR检测阴性的受试者闲置床小时数更少(28.6±25.2对75.3±70.5;P<0.001)。占用闲置床位的预期收入和避免的CP成本在214,160美元至268,340美元之间,超过了项目成本。
一项基于PCR的针对性筛查清除MRSA定植的项目带来了预期收入,并降低了CP成本,且收入超过了项目成本。